Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model

Publisher: 'Elsevier BV'

DOI identifier: 10.1016/j.leukres.2013.10.014

OAI identifier:

Provided by: MUCC (Crossref)

Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.